The DOI matches its Crossref record; 256 of the 256 references it cites were found in a registry or an index.
Handling uncertainty when performing economic evaluation of healthcare interventions.
Open accessAbstract
NHS R&D HTA ProgrammeT he overall aim of the NHS R&D Health Technology Assessment (HTA) programme is to ensure that high-quality research information on the costs, effectiveness and broader impact of health technologies is produced in the most efficient way for those who use, manage and work in the NHS.Research is undertaken in those areas where the evidence will lead to the greatest benefits to patients, either through improved patient outcomes or the most efficient use of NHS resources.The Standing Group on Health Technology advises on national priorities for health technology assessment.Six advisory panels assist the Standing Group in identifying and prioritising projects.These priorities are then considered by the HTA Commissioning Board supported by the National Coordinating Centre for HTA (NCCHTA).This report is one of a series covering acute care, diagnostics and imaging, methodology, pharmaceuticals, population screening, and primary and community care.It was identified as a priority by the Methodology Panel and funded as project number 93/48/07.The views expressed in this publication are those of the authors and not necessarily those of the Standing Group, the Commissioning Board, the Panel members or the Department of Health.The editors wish to emphasise that funding and publication of this research by the NHS should not be taken as implicit support for the recommendations for policy contained herein.In particular, policy options in the area of screening will be considered by the National Screening Committee.This Committee, chaired by the Chief Medical Officer, will take into account the views expressed here, further available evidence and other relevant considerations.Reviews in Health Technology Assessment are termed 'systematic' when the account of the search, appraisal and synthesis methods (to minimise biases and random errors) would, in theory, permit the replication of the review by others.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736
Cost-Effectiveness in Health and Medicine
(1996) · doi:10.1093/oso/9780195108248.001.0001 · Cited by 7,193
Practical Statistics for Medical Research.
Bartko, J. J., & Altman, D. G. (1992) · Journal of the American Statistical Association · doi:10.2307/2290246 · Cited by 4,797
Statistical Methods in Medical Research.
Armitage, P. (1972) · Biometrics · doi:10.2307/2556182 · Cited by 4,029
An Introduction to the Bootstrap
Grimshaw, S. D., Efron, B., & Tibshirani, R. J. (1995) · Technometrics · doi:10.2307/1269918 · Cited by 2,095
Guidelines for authors and peer reviewers of economic submissions to the BMJ
Drummond, M. F., & Jefferson, T. O. (1996) · BMJ · doi:10.1136/bmj.313.7052.275 · Cited by 1,827
Laupacis, A., Feeny, D. H., Detsky, A. S., & Tugwell, P. (1992) · Europe PMC (PubMed Central) · Cited by 1,581
The Threshold Approach to Clinical Decision Making
Pauker, S. G., & Kassirer, J. P. (1980) · New England Journal of Medicine · doi:10.1056/nejm198005153022003 · Cited by 1,358
Explanatory and pragmatic attitudes in therapeutical trials
Schwartz, D., & Lellouch, J. (1967) · Journal of Chronic Diseases · doi:10.1016/0021-9681(67)90041-0 · Cited by 1,185
A study of the quality of life and cost-utility of renal transplantation
Laupacis, A., Keown, P., Pus, N., Krueger, H., Ferguson, B., Wong, C., & Muirhead, N. (1996) · Kidney International · doi:10.1038/ki.1996.307 · Cited by 1,167
The friction cost method for measuring indirect costs of disease
Koopmanschap, M. A., Rutten, F. F. H., van Ineveld, B. M., & van Roijen, L. (1995) · Journal of Health Economics · doi:10.1016/0167-6296(94)00044-5 · Cited by 1,137
Costs, effects and C/E‐ratios alongside a clinical trial
Van Hout, B. A., Al, M. J., Gordon, G. S., & Rutten, F. F. H. (1994) · Health Economics · doi:10.1002/hec.4730030505 · Cited by 964
Briggs, A. H., Wonderling, D. E., & Mooney, C. Z. (1997) · Health Economics · doi:10.1002/(sici)1099-1050(199707)6:4<327::aid-hec282>3.0.co;2-w · Cited by 882
Probabilistic Sensitivity Analysis Using Monte Carlo Simulation: A Practical Approach
Doubilet, P., Begg, C. B., Weinstein, M. C., Braun, P., & McNeil, B. J. (1985) · Medical Decision Making · doi:10.1177/0272989x8500500205 · Cited by 860
Utilities and Quality-Adjusted Life Years
Torrance, G. W., & Feeny, D. (1989) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300008461 · Cited by 818
Economic foundations of cost-effectiveness analysis
Garber, A. M., & Phelps, C. E. (1997) · Journal of Health Economics · doi:10.1016/s0167-6296(96)00506-1 · Cited by 766
Health-related quality of life measurement for evaluation research and policy analysis.
Kaplan, R. M., & Bush, J. W. (1982) · Health Psychology · doi:10.1037/0278-6133.1.1.61 · Cited by 666
Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis
Briggs, A., Sculpher, M., & Buxton, M. (1994) · Health Economics · doi:10.1002/hec.4730030206 · Cited by 521
Mark, D. B., Hlatky, M. A., Califf, R. M., Naylor, C. D., Lee, K. L., Armstrong, P. W., Barbash, G., White, H., Simoons, M. L., Nelson, C. L., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505253322106 · Cited by 521
The Cost Effectiveness of Preoperative Autologous Blood Donations
Etchason, J., Petz, L., Keeler, E., Calhoun, L., Kleinman, S., Snider, C., Fink, A., & Brook, R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503163321106 · Cited by 495
Quality-adjusted life years, utility theory, and healthy-years equivalents
Mehrez, A., & Gafni, A. (1989) · Medical Decision Making · doi:10.1177/0272989x8900900209 · Cited by 469
Economic Evaluation of Neonatal Intensive Care of Very-Low-Birth-Weight Infants
Boyle, M. H., Torrance, G. W., Sinclair, J. C., & Horwood, S. P. (1983) · New England Journal of Medicine · doi:10.1056/nejm198306023082206 · Cited by 464
Udvarhelyi, I. S., Colditz, G. A., Rai, A., & Epstein, A. M. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-3-238 · Cited by 413
Cost-Effectiveness of Detecting and Treating Diabetic Retinopathy
Javitt, J. C., & Aiello, L. P. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-1_part_2-199601011-00017 · Cited by 411
O??Brien, B. J., Drummond, M. F., Labelle, R. J., & William, A. (1994) · Medical Care · doi:10.1097/00005650-199402000-00006 · Cited by 405
The use of QALYs in health care decision making
Loomes, G., & McKenzie, L. (1989) · Social Science & Medicine · doi:10.1016/0277-9536(89)90030-0 · Cited by 374
Screening for prostate cancer. A decision analytic view
Krahn, M. D. (1994) · JAMA · doi:10.1001/jama.272.10.773 · Cited by 371
Sarasin, F. P., Giostra, E., & Hadengue, A. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00197-0 · Cited by 368
Goldman, L. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03460090093039 · Cited by 357
Tabar, L., Fagerberg, G., Duffy, S. W., & Day, N. E. (1989) · Journal of Epidemiology and Community Health · doi:10.1136/jech.43.2.107 · Cited by 355
Economic Analysis Alongside Clinical Trials: Revisiting the Methodological Issues
Drummond, M. F., & Davies, L. (1991) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300007121 · Cited by 337
Parsonnet, J., Harris, R. A., Hack, H. M., & Owens, D. K. (1996) · The Lancet · doi:10.1016/s0140-6736(96)01501-2 · Cited by 333
Gage, B. F. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530230025025 · Cited by 329
Hs, M. (1995) · JAMA · doi:10.1001/jama.274.15.1201 · Cited by 323
ESTIMATING CONFIDENCE INTERVALS FOR COST-EFFECTIVENESS RATIOS: AN EXAMPLE FROM A RANDOMIZED TRIAL
CHAUDHARY, M. A., & STEARNS, S. C. (1996) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19960715)15:13<1447::aid-sim267>3.0.co;2-v · Cited by 313
The Cost-effectiveness of Counseling Smokers to Quit
Cummings, S. R. (1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03420010085038 · Cited by 294
Confidence Intervals for Cost-Effectiveness Ratios: A Comparison of Four Methods
Polsky, D., Glick, H. A., Willke, R., & Schulman, K. (1997) · Health Economics · doi:10.1002/(sici)1099-1050(199705)6:3<243::aid-hec269>3.0.co;2-z · Cited by 282
Long-term Cost-effectiveness of Various Initial Monotherapies for Mild to Moderate Hypertension
Edelson, J. T. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03440030094028 · Cited by 278
Cost effectiveness/utility analyses
Birch, S., & Gafni, A. (1992) · Journal of Health Economics · doi:10.1016/0167-6296(92)90004-k · Cited by 275
Cost Effectiveness Analysis Applied to the Treatment of Chronic Renal Disease
Klarman, H. E., Francis, J. O., & Rosenthal, G. D. (1968) · Medical Care · doi:10.1097/00005650-196801000-00005 · Cited by 271
Cost-effectiveness of a Routine Varicella Vaccination Program for US Children
Lieu, T. A. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510290057037 · Cited by 270
The cost‐effectiveness of preoperative autologous blood donation for total hip and knee replacement
Birkmeyer, J. D., Goodnough, L. T., AuBuchon, J. P., Noordsij, P. G., & Littenberg, B. (1993) · Transfusion · doi:10.1046/j.1537-2995.1993.33793325048.x · Cited by 266
Revascularization for femoropopliteal disease. A decision and cost-effectiveness analysis
Hunink, M. G. M. (1995) · JAMA · doi:10.1001/jama.274.2.165 · Cited by 264
Beyond the confidence interval.
Poole, C. (1987) · American Journal of Public Health · doi:10.2105/ajph.77.2.195 · Cited by 253
Cost-effectiveness league tables: More harm than good?
Drummond, M., Torrance, G., & Mason, J. (1993) · Social Science & Medicine · doi:10.1016/0277-9536(93)90315-u · Cited by 249
Cleary, P. D. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470010077034 · Cited by 240
Hillner, B. E., & Smith, T. J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101173240305 · Cited by 237
Hillman, A. L., Eisenberg, J. M., Pauly, M. V., Bloom, B. S., Click, H., Kinosian, B., & Schwartz, J. S. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105093241911 · Cited by 234
The Measurement of Patients' Values in Medicine
Llewellyn-Thomas, H., Sutherland, H. J., Tibshirani, R., Ciampi, A., Till, J. E., & Boyd, N. F. (1982) · Medical Decision Making · doi:10.1177/0272989x8200200407 · Cited by 232
Cost-Effectiveness of Interventions to Prevent or Treat Coronary Heart Disease
Weinstein, M. C., & Stason, W. B. (1985) · Annual Review of Public Health · doi:10.1146/annurev.pu.06.050185.000353 · Cited by 222
Cost-Effectiveness of Coronary Artery Bypass Surgery
Stason, W. B., & Weinstein, M. C. (1985) · Return to Work After Coronary Artery Bypass Surgery · doi:10.1007/978-3-642-69855-2_42 · Cited by 221
Tosteson, A. N. A., Rosenthal, D. I., Melton, L. J., & Weinstein, M. C. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-8-594 · Cited by 221
Some guidelines on the use of cost effectiveness league tables.
Mason, J., Drummond, M., & Torrance, G. (1993) · BMJ · doi:10.1136/bmj.306.6877.570 · Cited by 220
Economic evaluation of cardiac rehabilitation soon after acute myocardial infarction
Oldridge, N., Furlong, W., Feeny, D., Torrance, G., Guyatt, G., Crowe, J., & Jones, N. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90152-3 · Cited by 208
Hornberger, J. C., Redelmeier, D. A., & Petersen, J. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90099-9 · Cited by 206
Krumholz, H. M., Pasternak, R. C., Weinstein, M. C., Friesinger, G. C., Ridker, P. M., Tosteson, A. N. A., & Goldman, L. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207023270102 · Cited by 206
Jaakkimainen, L., Goodwin, P. J., Pater, J., Warde, P., Murray, N., & Rapp, E. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.8.1301 · Cited by 205
The Decision Rules of Cost-Effectiveness Analysis
Karlsson, G., & Johannesson, M. (1996) · PharmacoEconomics · doi:10.2165/00019053-199609020-00003 · Cited by 205
Qaly league tables: Handle with care
Gerard, K., & Mooney, G. (1993) · Health Economics · doi:10.1002/hec.4730020108 · Cited by 204
Fiscella, K. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530400035035 · Cited by 204
Cost Effectiveness of Prophylactic Intravenous Immune Globulin in Chronic Lymphocytic Leukemia
Weeks, J. C., Tierney, M. R., & Weinstein, M. C. (1991) · New England Journal of Medicine · doi:10.1056/nejm199107113250202 · Cited by 204
Patterson, R. E., Eisner, R. L., & Horowitz, S. F. (1995) · Circulation · doi:10.1161/01.cir.91.1.54 · Cited by 197
Goldman, L., Sia, S. T. B., Cook, E. F., Rutherford, J. D., & Weinstein, M. C. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807213190306 · Cited by 197
A cost-effectiveness analysis of exercise as a health promotion activity.
Hatziandreu, E. I., Koplan, J. P., Weinstein, M. C., Caspersen, C. J., & Warner, K. E. (1988) · American Journal of Public Health · doi:10.2105/ajph.78.11.1417 · Cited by 193
Intensive care, survival, and expense of treating critically ill cancer patients
Schapira, D. V. (1993) · JAMA · doi:10.1001/jama.269.6.783 · Cited by 192
Cost effectiveness of chemotherapy for pulmonary tuberculosis in three sub-Saharan African countries
Murray, C. J. L., DeJonghe, E., Chum, H. J., Nyangulu, D. S., Salomao, A., & Styblo, K. (1991) · The Lancet · doi:10.1016/0140-6736(91)92600-7 · Cited by 191
Confidence intervals for cost-effectiveness ratios: An application of Fieller's theorem
Willan, A. R., & OʼBrien, B. J. (1996) · Health Economics · Cited by 189
Developing the Health Care Market
Maynard, A. (1991) · The Economic Journal · doi:10.2307/2234443 · Cited by 185
Wong, J. B., Sonnenberg, F. A., Salem, D. N., & Pauker, S. G. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-11-852 · Cited by 179
Oster, G. (1987) · JAMA · doi:10.1001/jama.258.17.2381 · Cited by 179
Brouwer, W. B. F., Koopmanschap, M. A., & Rutten, F. F. H. (1997) · Health Economics · doi:10.1002/(sici)1099-1050(199705)6:3<253::aid-hec266>3.0.co;2-6 · Cited by 178
Jonsson, B., Johannesson, M., Kjekshus, J., Olsson, A. G., Pedersen, T. R., Wedel, H., & Scandlnavlan Simvastatin Survival Study Group (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a014994 · Cited by 176
Gafni, A., & Birch, S. (1993) · Europe PMC (PubMed Central) · Cited by 175
Cost-effectiveness of laparoscopic cholecystectomy versus open cholecystectomy
Bass, E. B., Pitt, H. A., & Lillemoe, K. D. (1993) · The American Journal of Surgery · doi:10.1016/s0002-9610(05)80942-0 · Cited by 174
Cost-effectiveness of Nicotine Gum as an Adjunct to Physician's Advice Against Cigarette Smoking
Oster, G. (1986) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1986.03380100089026 · Cited by 174
Identifying relevant studies for systematic reviews
Clarke, M., & Greaves, L. (1995) · BMJ · doi:10.1136/bmj.310.6981.741a · Cited by 174
Mynors-Wallis, L., Davies, I., Gray, A., Barbour, F., & Gath, D. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.170.2.113 · Cited by 167
Problems of using modelling in the economic evaluation of health care
Sheldon, T. (1996) · Health Economics · doi:10.1002/(sici)1099-1050(199601)5:1<13::aid-hec182>3.0.co;2-j · Cited by 163
Kent, K. C. (1995) · JAMA · doi:10.1001/jama.1995.03530110050035 · Cited by 161
Cutting into cholesterol. Cost-effective alternatives for treating hypercholesterolemia
Kinosian, B. P. (1988) · JAMA · doi:10.1001/jama.259.15.2249 · Cited by 157
Cost Effectiveness of Vaccination against Pneumococcal Pneumonia
Willems, J. S., Cr, S., Riddiough, M. A., & Bell, J. C. (1980) · New England Journal of Medicine · doi:10.1056/nejm198009043031004 · Cited by 155
Pharoah, P. D. P., & Hollingworth, W. (1996) · BMJ · doi:10.1136/bmj.312.7044.1443 · Cited by 155
Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer
Glimelius, B. L. G., Hoffman, K., Graf, W. D., et al. (1995) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a059157 · Cited by 151
Cost-Effectiveness of Lumbar Discectomy for the Treatment of Herniated Intervertebral Disc
Malter, A. D., Larson, E. B., Urban, N. D., & Deyo, R. A. (1996) · Spine · doi:10.1097/00007632-199605010-00011 · Cited by 148
Cost-utility in practice: A policy maker's guide to the state of the art
Gerard, K. (1992) · Health Policy · doi:10.1016/0168-8510(92)90022-4 · Cited by 141
Hillner, B. E. (1992) · JAMA · doi:10.1001/jama.1992.03480150061038 · Cited by 139
Cohen, D. J., Breall, J., Ho, K., Kuntz, R., Goldman, L., Baim, D., & Weinstein, M. C. (1994) · Circulation · doi:10.1161/01.cir.89.4.1859 · Cited by 138
Cost-effectiveness of a smoking cessation program after myocardial infarction
Krumholz, H. M., Cohen, B. J., Tsevat, J., Pasternak, R. C., & Weinstein, M. C. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90598-u · Cited by 137
Productivity costs in cost-effectiveness analysis: numerator or denominator: a further discussion
Brouwer, W. B. F., Koopmanschap, M., & Rutten, F. (1997) · Health Economics · doi:10.1002/(sici)1099-1050(199709)6:5<511::aid-hec297>3.0.co;2-k · Cited by 136
Cost Effectiveness of Cervical Cancer Screening for the Elderly
Fahs, M. C., Mandelblatt, J. S., Schechter, C. B., & Muller, C. F. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-6-520 · Cited by 136
From cost–effectiveness ratios to resource allocation: where to draw the line?
Weinstein, M. C. (1995) · Cambridge University Press eBooks · doi:10.1017/cbo9780511625817.005 · Cited by 135
Schulman, K. A., Lynn, L. A., Glick, H. A., & Eisenberg, J. M. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-798 · Cited by 134
Cost-Effective Care of End-Stage Renal Disease: A Billion Dollar Question
Roberts, S. D., MAXWELL, D. R., & GROSS, T. L. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-2-243 · Cited by 134
A cost utility analysis of mammography screening in Australia
Hall, J. P., Gerard, K., Salkeld, G. P., & Richardson, J. R. J. (1992) · Social Science & Medicine · doi:10.1016/0277-9536(92)90130-i · Cited by 134
Treatment of chronic type B and C hepatitis with interferon alfa: An economic appraisal
Dusheiko, G. M., & Roberts, J. A. (1995) · Hepatology · doi:10.1002/hep.1840220636 · Cited by 133
The Cost-effectiveness of Mammographic Screening Strategies
Lindfors, K. K. (1995) · JAMA · doi:10.1001/jama.1995.03530110043033 · Cited by 132
Predicting Treatment Costs and Life Expectancy for End-Stage Renal Disease
Stange, P. V., & Sumner, A. T. (1978) · New England Journal of Medicine · doi:10.1056/nejm197802162980705 · Cited by 132
Cost-effectiveness of captopril therapy after myocardial infarction
Tsevat, J., Duke, D., Goldman, L., Pfeffer, M. A., Lamas, G. A., Soukup, J. R., Kuntz, K. M., & Lee, T. H.-Y. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00284-1 · Cited by 127
Kattlove, H., Liberati, A., Keeler, E., & Brook, R. H. (1995) · JAMA · doi:10.1001/jama.273.2.142 · Cited by 127
DAY-CASE SURGERY FOR HERNIAS AND HÆMORRHOIDS
Russell, I. T., Fell, M., Devlin, H. B., Glass, N., & NEWELL, D. J. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92790-8 · Cited by 125
Cost-effectiveness of Routine Coronary Angiography After Acute Myocardial Infarction
Kuntz, K. M., Tsevat, J., Goldman, L., & Weinstein, M. C. (1996) · Circulation · doi:10.1161/01.cir.94.5.957 · Cited by 125
Cesarean delivery for women presenting with genital herpes lesions. Efficacy, risks, and costs
Randolph, A. G. (1993) · JAMA · doi:10.1001/jama.270.1.77 · Cited by 125
Busch, M. P., Korelitz, J., Kleinman, S. H., Lee, S. R., AuBuchon, J. P., & Schreiber, G. B. (1995) · Transfusion · doi:10.1046/j.1537-2995.1995.351196110893.x · Cited by 123
Cost-Effectiveness of Screening for Asymptomatic Carotid Atherosclerotic Disease
Derdeyn, C. P., & Powers, W. J. (1996) · Stroke · doi:10.1161/01.str.27.11.1944 · Cited by 120
Elective surgery for asymptomatic, unruptured, intracranial aneurysms: a cost-effectiveness analysis
King, J. T., Glick, H. A., Mason, T. J., & Flamm, E. S. (1995) · Journal of neurosurgery · doi:10.3171/jns.1995.83.3.0403 · Cited by 115
Cost-benefit analysis of hip fracture treatment
Parker, M., Myles, J. W., Anand, J., & Drewett, R. (1992) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.74b2.1544965 · Cited by 111
Tosteson, A. N. A., Goldman, L., Udvarhelyi, I. S., & Lee, T. H.-Y. (1996) · Circulation · doi:10.1161/01.cir.94.2.143 · Cited by 111
Mechanical Ventilation for the Elderly Patient in Intensive Care
Cohen, I. L. (1993) · JAMA · doi:10.1001/jama.269.8.1025 · Cited by 110
Paul, S. D. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420100129016 · Cited by 109
Goodnough, L. T., Grishaber, J. E., Birkmeyer, J. D., Monk, T. G., & Catàlona, W. J. (1994) · Urology · doi:10.1016/s0090-4295(94)80136-3 · Cited by 109
Cost-Effectiveness of Hormone Replacement Therapy in the Menopause
Weinstein, M. C., & Schiff, I. (1983) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198308000-00001 · Cited by 109
Larsen, G. C., Manolis, A. S., Sonnenberg, F. A., Beshansky, J. R., Estes, N. A. M., & Pauker, S. G. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90341-j · Cited by 108
Clemens, J. D., & Ransohoff, D. F. (1984) · Journal of Chronic Diseases · doi:10.1016/0021-9681(84)90004-3 · Cited by 108
Costs And Benefits Of Routine Varicella Vaccination In German Children
Beutels, P., Clara, R., Tormans, G., van Doorslaer, E. K. A., & Damme, P. V. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/174.supplement_3.s335 · Cited by 108
Valuing health care benefits in money terms
Pauly, M. V. (1995) · Cambridge University Press eBooks · doi:10.1017/cbo9780511625817.006 · Cited by 107
Cost-effectiveness of Screening for Hereditary Hemochromatosis
Phatak, P. D. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.7.769 · Cited by 107
Breastfeeding promotion and priority setting in health
Horton, S., Sanghvi, T. G., PHILLIPS, M., Fiedler, J. L., Pérez‐Escamilla, R., Lutter, C. K., Rivera, A., & Segall‐Corrêa, A. M. (1996) · Health Policy and Planning · doi:10.1093/heapol/11.2.156 · Cited by 106
Are Clinical Trials a Cost-effective Investment?
Detsky, A. S. (1989) · JAMA · doi:10.1001/jama.1989.03430130071037 · Cited by 105
O’Brien, B. J., Anderson, D. R., & Goeree, R. A. (1994) · PubMed · Cited by 105
An Economic Analysis of Captopril in the Treatment of Diabetic Nephropathy
Rodby, R. A., Firth, L. M., Lewis, E. J., & The Collaborative Study Group (1996) · Diabetes Care · doi:10.2337/diacare.19.10.1051 · Cited by 104
Screening to prevent renal failure in insulin dependent diabetic patients: an economic evaluation
Kiberd, B. A., & Jindal, K. K. (1995) · BMJ · doi:10.1136/bmj.311.7020.1595 · Cited by 102
Holtgräve, D. R., & Kelly, J. A. (1996) · American Journal of Public Health · doi:10.2105/ajph.86.10.1442 · Cited by 100
Smith, T. J., & Hillner, B. E. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.4.771 · Cited by 99
Wachter, R. M. (1995) · JAMA · doi:10.1001/jama.1995.03520270064033 · Cited by 99
Prescribing selective serotonin reuptake inhibitors as strategy for prevention of suicide
Freemantle, N., House, A. O., Song, F., Mason, J. M., & Sheldon, T. (1994) · BMJ · doi:10.1136/bmj.309.6949.249 · Cited by 98
Quality Adjusted Life Years Added by Treatment of Obstructive Sleep Apnea
Tousignant, P., Cosio, M. G., Levy, R. D., & Groome, P. A. (1994) · SLEEP · doi:10.1093/sleep/17.1.52 · Cited by 97
Cost-effectiveness of HA-1A Monoclonal Antibody for Gram-Negative Sepsis
Schulman, K. A. (1991) · JAMA · doi:10.1001/jama.1991.03470240088039 · Cited by 97
Hutton, J., Brown, R. E., Borowitz, M., Abrams, K. R., Rothman, M., & Shakespeare, A. (1996) · PharmacoEconomics · doi:10.2165/00019053-199600092-00004 · Cited by 96
Discounting and health benefits: Another Perspective
Cairns, J. (1992) · Health Economics · doi:10.1002/hec.4730010111 · Cited by 95
Nichol, G., Laupacis, A., Stiell, I. G., O’Rourke, K., Anis, A. H., Bolley, H. B., & Detsky, A. S. (1996) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(96)70188-9 · Cited by 94
Statistical Inference for Cost-Effectiveness Ratios
LASKA, E. M., Meisner, M., & Siegel, C. (1997) · Health Economics · Cited by 91
Butler, W. E., Barker, F. G., Hayward, B., & Harkness, W. F. J. (1996) · Neurosurgery · doi:10.1097/00006123-199603000-00018 · Cited by 90
Cost-effectiveness Analysis of End-stage Renal Disease Treatments
Garner, T. I., & Dardis, R. (1987) · Medical Care · doi:10.1097/00005650-198701000-00004 · Cited by 90
Strategies for reducing coronary risk factors in primary care: which is most cost effective?
Field, K., Thorogood, M., Silagy, C. A., et al. (1995) · BMJ · doi:10.1136/bmj.310.6987.1109 · Cited by 90
Hamilton, V. H. (1995) · JAMA · doi:10.1001/jama.1995.03520370074040 · Cited by 89
Is Prevention Better than Cure?
Sommers, K. B., & Russell, L. B. (1986) · Journal of Public Health Policy · doi:10.2307/3342130 · Cited by 86
Anticoagulation for Noncardiac Procedures in Patients With Prosthetic Heart Valves
Eckman, M. H. (1990) · JAMA · doi:10.1001/jama.1990.03440110079032 · Cited by 85
Hatziandreu, E. J., Brown, R. E., Revicki, D. A., Turner, R. R., Martindale, J. J., Levine, S., & Siegel, J. E. (1994) · PharmacoEconomics · doi:10.2165/00019053-199405030-00008 · Cited by 85
Siegel, J. E., Królewski, A. S., Warram, J. H., & Weinstein, M. C. (1992) · Journal of the American Society of Nephrology · doi:10.1681/asn.v34s111 · Cited by 85
Probabilistic sensitivity analysis methods for general decision models
Critchfield, G. C., Willard, K. E., & Connelly, D. P. (1986) · Computers and Biomedical Research · doi:10.1016/0010-4809(86)90020-0 · Cited by 84
Cook, J., Richardson, J. R. J., & Street, A. (1994) · Health Economics · doi:10.1002/hec.4730030305 · Cited by 83
The Role of Exercise Testing in Screening for Coronary Artery Disease
Sox, H. C., Littenberg, B., & Garber, A. M. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-110-6-456 · Cited by 82
Economic Evaluation of A Support Program for Caregivers of Demented Elderly
Drummond, M., Mohide, E. A., Tew, M., Streiner, D. L., Pringle, D. M., & Gilbert, J. R. (1991) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300005109 · Cited by 81
Goossens, M. E. J. B., Mölken, M. R., Leidl, R., Bos, S., Vlaeyen, J. W. S., & Teeken-Gruben, N. J. (1996) · PubMed · Cited by 80
Reflecting Uncertainty in Cost-Effectiveness Analysis
Manning, W. G., Fryback, D. G., & Weinstein, M. C. (1996) · doi:10.1093/oso/9780195108248.003.0008 · Cited by 80
Cost-effectiveness of fracture prevention in established osteoporosis
Jönsson, B., Christiansen, C., Johnell, O., & Hedbrandt, J. (1995) · Osteoporosis International · doi:10.1007/bf01623315 · Cited by 79
Wonderling, D. E., Langham, S., Buxton, M. J., Normand, C. E. M., & McDermott, C. (1996) · BMJ · doi:10.1136/bmj.312.7041.1274 · Cited by 79
Kristiansen, I. S., Eggen, A. E., & Thelle, D. S. (1991) · BMJ · doi:10.1136/bmj.302.6785.1119 · Cited by 77
Summing up: The Science of Reviewing Research
Stolp, C., Light, R. J., & Pillemer, D. B. (1985) · Journal of Policy Analysis and Management · doi:10.2307/3323437 · Cited by 77
Combination Antiretroviral Therapy in HIV Infection
Moore, R. D., & Bartlett, J. G. (1996) · PharmacoEconomics · doi:10.2165/00019053-199610020-00002 · Cited by 76
Conroy, R. M., O'Brien, E. T., O'MALLEY, K., et al. (1993) · BMJ · doi:10.1136/bmj.306.6888.1319 · Cited by 75
Cervical‐cancer screening: Attendance and cost‐effectiveness
Koopmanschap, M. A., van Oortmarssen, G. J., van Agt, H. M. A., van Ballegooijen, M., Habbema, J. D. F., & Lubbe, K. T. N. (1990) · International Journal of Cancer · doi:10.1002/ijc.2910450305 · Cited by 74
An economic evaluation of lovastatin for cholesterol lowering and coronary artery disease reduction
Hay, J. W., Wittels, E. H., & Gotto, A. M. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90609-o · Cited by 73
The Cost-effectiveness of Cervical Cancer Screening for Low-Income Elderly Women
Mandelblatt, J. S. (1988) · JAMA · doi:10.1001/jama.1988.03720160029025 · Cited by 73
Nease, R. F., & Owens, D. K. (1994) · Medical Decision Making · doi:10.1177/0272989x9401400409 · Cited by 72
The Analysis of Censored Treatment Cost Data in Economic Evaluation
Fenn, P., McGuire, A. J., Phillips, V., Backhouse, M. E., & Jones, D. A. (1995) · Medical Care · doi:10.1097/00005650-199508000-00009 · Cited by 70
Evaluating and improving the cost-effectiveness of the implantable cardioverter—defibrillator
Kupersmith, J., Hogan, A. J., Guerrero, P., Gardiner, J. C., Mellits, E. D., Baumgardner, R. A., Rovner, D. R., Holmes-Rovner, M. M., Mclane, A., Levine, J. H., et al. (1995) · American Heart Journal · doi:10.1016/0002-8703(95)90359-3 · Cited by 70
The community psychiatric nurse in primary care: an economic analysis
Gournay, K., & Brooking, J. (1995) · Journal of Advanced Nursing · doi:10.1046/j.1365-2648.1995.22040769.x · Cited by 68
Eckman, M. H., Levine, H. J., Salem, D. N., & Pauker, S. G. (1998) · CHEST Journal · doi:10.1378/chest.114.5_supplement.699s · Cited by 68
Johannesson, M., Dahlöf, B., Lindholm, L. H., Ekbom, T., Hansson, L., Odén, A., Scherstén, B., Wester, P. O., & Jönsson, B. (1993) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1993.tb00749.x · Cited by 68
Danese, M. D. (1996) · JAMA · doi:10.1001/jama.276.4.285 · Cited by 68
The Use of “Quality-Adjusted Life Years” (QALYs) to Evaluate Treatment in Intensive Care
Kerridge, R. K., Glasziou, P., & Hillman, K. (1995) · Anaesthesia and Intensive Care · doi:10.1177/0310057x9502300309 · Cited by 67
Cost utility analysis of maintenance treatment for recurrent depression
Kamlet, M. S., Paul, N., Greenhouse, J. B., Kupfer, D. J., Frank, E., & Wade, M. (1995) · Controlled Clinical Trials · doi:10.1016/0197-2456(94)00020-4 · Cited by 67
The Cost Effectiveness of Hypertension Treatment in Sweden
Johannesson, M. (1995) · PharmacoEconomics · doi:10.2165/00019053-199507030-00008 · Cited by 67
A health-economic comparison of diet and drug treatment in obese men with mild hypertension
Johannesson, M., & Fagerberg, B. R. (1992) · Journal of Hypertension · doi:10.1097/00004872-199209000-00022 · Cited by 67
Patterson, R. E., Eng, C., Horowitz, S. F., Gorlin, R., & Goldstein, S. R. (1984) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(84)80214-4 · Cited by 65
A cost-effectiveness analysis of the treatment of chronic renal failure
Ludbrook, A. (1981) · Applied Economics · doi:10.1080/00036848100000004 · Cited by 65
The Costs and Effects of Behavioral Programs in Chronic Obstructive Pulmonary Disease
Toevs, C. D., Kaplan, R. M., & Atkins, C. J. (1984) · Medical Care · doi:10.1097/00005650-198412000-00004 · Cited by 63
Cost-effectiveness of ticlopidine in preventing stroke in high-risk patients.
Oster, G., Huse, D. M., Lacey, M. J., & Epstein, A. M. (1994) · Stroke · doi:10.1161/01.str.25.6.1149 · Cited by 62
Hogenhuis, W., Stevens, S. K., Wang, P. J., Wong, J. B., Manolis, A. S., Estes, N. A. M., & Pauker, S. G. (1993) · PubMed · Cited by 62
Modelling the Cost Effectiveness of Antidepressant Treatment in Primary Care
Revicki, D. A., Brown, R. E., Palmer, W., Bakish, D., Rosser, W., Anton, S. F., & Feeny, D. H. (1995) · PharmacoEconomics · doi:10.2165/00019053-199508060-00007 · Cited by 61
Gabriel, S. E., Campion, M. E., & O'Fallon, W. M. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370306 · Cited by 61
Goldman, L., Goldman, P. A., Williams, L. W., & Weinstein, M. C. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90015-5 · Cited by 60
Analysis of a tuberculin testing program using a health status index
Bush, J. W., Fanshel, S., & Chen, M. M. (1972) · Socio-Economic Planning Sciences · doi:10.1016/0038-0121(72)90006-7 · Cited by 59
How cost-effective is breast cancer screening in different EC countries?
van Ineveld, B. M., van Oortmarssen, G. J., de Koning, H. J., et al. (1993) · European Journal of Cancer · doi:10.1016/0959-8049(93)90100-t · Cited by 58
Cost‐Effectiveness of Hormone Replacement
Weinstein, M. C., & Tosteson, A. N. A. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb30324.x · Cited by 57
A Cost-Effectiveness Analysis of Continuous Ambulatory Peritoneal Dialysis and Hospital Hemodialysis
Churchill, D. N., Lemon, B. C., & Torrance, G. W. (1984) · Medical Decision Making · doi:10.1177/0272989x8400400411 · Cited by 57
AuBuchon, J. P., & Littenberg, B. (1996) · Transfusion · doi:10.1046/j.1537-2995.1996.36396182139.x · Cited by 57
Cost effectiveness of cholesterol-lowering therapy in The Netherlands
Martens, L. L., Rutten, F., Erkelens, D. W., & Ascoop, C. A. P. L. (1989) · The American Journal of Medicine · doi:10.1016/s0002-9343(89)80600-x · Cited by 55
Detection of recurrence after surgery for colorectal cancer
Kievit, J., & Bruinvels, D. J. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(95)00155-c · Cited by 55
Statistical Analysis in Pharmacoeconomic Studies
Coyle, D. (1996) · PharmacoEconomics · doi:10.2165/00019053-199609060-00005 · Cited by 54
Cost-effectiveness of cataract surgery in a public health eye care programme in Nepal.
Marseille, E. A. (1996) · Europe PMC (PubMed Central) · Cited by 54
Pragmatic Versus Explanatory Trials
MacRae, K. D. (1989) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300007406 · Cited by 54
A Relative Cost‐effectiveness Analysis of Different Methods of Screening for Diabetic Retinopathy
Sculpher, M. J., Buxton, M. J., Ferguson, B. A., Humphreys, J. E., Altman, J. F. B., Spiegelhalter, D. J., Kirby, A. J., Jacob, J., Bacon, H., Dudbridge, S. B., et al. (1991) · Diabetic Medicine · doi:10.1111/j.1464-5491.1991.tb01671.x · Cited by 52
Fox-Rushby, J. A., & Foord, F. (1996) · Health Policy · doi:10.1016/0168-8510(95)00774-1 · Cited by 52
The Cost Effectiveness of Therapeutic and Prophylactic Leukocyte Transfusion
Rosenshein, M. S., Farewell, V. T., Price, T. H., et al. (1980) · New England Journal of Medicine · doi:10.1056/nejm198005083021904 · Cited by 52
Martens, L. L., Rutten, F., Erkelens, D. W., & Ascoop, C. A. P. L. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)91252-2 · Cited by 52
A Model for Evaluating the Cost-Effectiveness of Cholesterol-Lowering Treatment
Glick, H. A., Heyse, J. F., Thompson, D., Epstein, R. S., Smith, M. E., & Oster, G. (1992) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300002403 · Cited by 52
Benefits of HIV screening of blood transfusions in Zambia
Foster, S. D., & Buvé, A. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91272-x · Cited by 50
Hepatitis B vaccination: the cost effectiveness of alternative strategies in England and Wales.
Mangtani, P., Hall, A. J., & Normand, C. E. M. (1995) · Journal of Epidemiology & Community Health · doi:10.1136/jech.49.3.238 · Cited by 50
Who should be screened for HIV infection? A cost-effectiveness analysis
McCarthy, B. D. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.153.9.1107 · Cited by 50
Cost-Utility Analysis of Group Living in Dementia Care
Wimo, A. B., Mattson, B., Krakau, I., Eriksson, T., Nelvig, A., & Karlsson, G. (1995) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300005250 · Cited by 49
Bootstrap Analyses of Cost Effectiveness in Antidepressant Pharmacotherapy
Obenchain, R. L., Melfi, C. A., Croghan, T. W., & Buesching, D. P. (1997) · PharmacoEconomics · doi:10.2165/00019053-199711050-00008 · Cited by 47
Prioritising elective care: a cost utility analysis of orthopaedics in the north west of England.
James, M., Leger, S. S., & Rowsell, K. V. (1996) · Journal of Epidemiology & Community Health · doi:10.1136/jech.50.2.182 · Cited by 47
Bennett, C. L., Matchar, D. B., McCrory, D., McLeod, D. G., Crawford, E. D., & Hillner, B. E. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960501)77:9<1854::aid-cncr15>3.0.co;2-z · Cited by 46
12 Cost-effectiveness of hormone replacement therapy after the menopause
Tosteson, A. N. A., & Weinstein, M. C. (1991) · Baillière s Clinical Obstetrics and Gynaecology · doi:10.1016/s0950-3552(05)80298-6 · Cited by 46
Screening for hemochromatosis in children of homozygotes: Prevalence and cost-effectiveness
Adams, P. C., Kertesz, A. E., & VALBERG, L. S. (1995) · Hepatology · doi:10.1002/hep.1840220617 · Cited by 46
Jordan, J. E., Marks, M. P., Lane, B., & Steinberg, G. K. (1996) · PubMed Central · Cited by 46
Cited by
Bayesian Approaches to Clinical Trials and Health‐Care Evaluation
Spiegelhalter, D. J., Abrams, K. R., & Myles, J. P. (2003) · Wiley eBooks · doi:10.1002/0470092602 · Cited by 1,673
Representing uncertainty: the role of cost‐effectiveness acceptability curves
Fenwick, E., Claxton, K., & Sculpher, M. (2001) · Health Economics · doi:10.1002/hec.635 · Cited by 1,110
Cost‐effectiveness acceptability curves – facts, fallacies and frequently asked questions
Fenwick, E., O'Brien, B. J., & Briggs, A. (2004) · Health Economics · doi:10.1002/hec.903 · Cited by 943
Ramsey, S. D., Willke, R. J., Glick, H., Reed, S. D., Augustovski, F., Jonsson, B., Briggs, A., & Sullivan, S. D. (2015) · Value in Health · doi:10.1016/j.jval.2015.02.001 · Cited by 811
Self-citationHandling Uncertainty in Cost-Effectiveness Models
Briggs, A. H. (2000) · PharmacoEconomics · doi:10.2165/00019053-200017050-00006 · Cited by 807
Metadata
- Authors
- Briggs, & Gray
- Venue
- Health Technology Assessment
- Published
- 1999
- Volume
- 3
- Issue
- 2
- Pages
- 1-134
- ISSN
- 1366-5278 (ISSN-L)
- 2046-4924
- OpenAlex
- W1571272128
- Cited by
- 387
- References
- 256
- FWCI
- 51.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.